{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Treatment of Migraine Headache in the Presence of Selective Serotonin Reuptake Use: Pharmacokinetic Considerations

Activity Steps

Purpose of Activity

To provide information about the pharmacokinetic considerations with treatment of migraine headache in the presence of SSRI use.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the pharmacokinetic considerations of triptan medication use for treatment of migraine headaches with co-morbid treatment of depression using selective serotonin reuptake inhibitors (SSRIs).
  2. Identify signs/symptoms of serotonin syndrome and management of patients with serotonin syndrome and severe toxicity.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.

Test Code: JNN0715
Published: Aug 2015
Expires: 6/4/2021
Collections: Migraine
Required Passing Score: 13/18 (72%)
Authors: Alyssa Liguori Macca, DNP, ARNP-BC
Specialties: Neurology, Pain Management